Matthew K. Ito

6.1k total citations · 6 hit papers
71 papers, 3.9k citations indexed

About

Matthew K. Ito is a scholar working on Surgery, Economics and Econometrics and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Matthew K. Ito has authored 71 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 44 papers in Surgery, 24 papers in Economics and Econometrics and 14 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Matthew K. Ito's work include Lipoproteins and Cardiovascular Health (43 papers), Pharmaceutical Economics and Policy (17 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers). Matthew K. Ito is often cited by papers focused on Lipoproteins and Cardiovascular Health (43 papers), Pharmaceutical Economics and Policy (17 papers) and Diabetes, Cardiovascular Risks, and Lipoproteins (12 papers). Matthew K. Ito collaborates with scholars based in United States, Brazil and Australia. Matthew K. Ito's co-authors include Terry A. Jacobson, Jerome D. Cohen, Eliot A. Brinton, Daniel J. Rader, Sarah D. de Ferranti, Mary P. McGowan, Patrick M. Moriarty, Kevin C. Maki, Edward A. Gill and Harold Bays and has published in prestigious journals such as Circulation, Clinical Infectious Diseases and The American Journal of Medicine.

In The Last Decade

Matthew K. Ito

71 papers receiving 3.8k citations

Hit Papers

5 papers align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report

2015 582 citations Terry A. Jacobson, Matthew K. Ito et al. Journal of clinical lipidology profile →
Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients

2011 465 citations Anne C. Goldberg, Paul N. Hopkins et al. Journal of clinical lipidology profile →
The Agenda for Familial Hypercholesterolemia

2015 450 citations Samuel S. Gidding, Mary Ann Champagne et al. Circulation profile →
Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients

2011 397 citations Anne C. Goldberg, Paul N. Hopkins et al. Journal of clinical lipidology profile →
Understanding Statin Use in America and Gaps in Patient Education (USAGE): An internet-based survey of 10,138 current and former statin users

2012 373 citations Jerome D. Cohen, Eliot A. Brinton et al. Journal of clinical lipidology profile →
National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summary

2014 364 citations Terry A. Jacobson, Matthew K. Ito et al. Journal of clinical lipidology profile →

Peers

Countries citing papers authored by Matthew K. Ito

Since Specialization

Citations

This map shows the geographic impact of Matthew K. Ito's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Matthew K. Ito with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Matthew K. Ito more than expected).

Fields of papers citing papers by Matthew K. Ito

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Matthew K. Ito. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Matthew K. Ito. The network helps show where Matthew K. Ito may publish in the future.

Co-authorship network of co-authors of Matthew K. Ito

This figure shows the co-authorship network connecting the top 25 collaborators of Matthew K. Ito. A scholar is included among the top collaborators of Matthew K. Ito based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Matthew K. Ito. Matthew K. Ito is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	The Agenda for Familial Hypercholesterolemia breakdown → 2015 ·Circulation ·Samuel S. Gidding, Mary Ann Champagne, Sarah D. de Ferranti, Joep C. Defesche, Matthew K. Ito, Joshua W. Knowles, Brian W. McCrindle, Frederick J. Raal, Daniel J. Rader, Raúl D. Santos, Maria F. Lopes‐Virella, Gerald F. Watts, Anthony S. Wierzbicki	450
2	Long-chain omega-3 fatty acids, fibrates and niacin as therapeutic options in the treatment of hypertriglyceridemia: A review of the literature 2015 ·Atherosclerosis ·Matthew K. Ito	50
3	The extent of familial hypercholesterolemia instruction in US schools and colleges of medicine, pharmacy, and osteopathic medicine 2015 ·Journal of clinical lipidology ·(unknown), (unknown), (unknown), P. Barton Duell, Matthew K. Ito	7
4	Challenges in the Diagnosis and Treatment of Homozygous Familial Hypercholesterolemia 2015 ·Drugs ·Matthew K. Ito, Gerald F. Watts	42
5	National Lipid Association Recommendations for Patient-Centered Management of Dyslipidemia: Part 1—Full Report breakdown → 2015 ·Journal of clinical lipidology ·Terry A. Jacobson, Matthew K. Ito, Kevin C. Maki, Carl E. Orringer, Harold Bays, Peter H. Jones, James M. McKenney, Scott M. Grundy, Edward A. Gill, Robert A. Wild, Don P. Wilson, W. Virgil Brown	582
6	National Lipid Association recommendations for patient-centered management of dyslipidemia: Part 1 – executive summary breakdown → 2014 ·Journal of clinical lipidology ·Terry A. Jacobson, Matthew K. Ito, Kevin C. Maki, Carl E. Orringer, Harold Bays, Peter H. Jones, James M. McKenney, Scott M. Grundy, Edward A. Gill, Robert A. Wild, Don P. Wilson, W. Virgil Brown	364
7	Coenzyme Q10 Ameliorates the Reduction in GLUT4 Transporter Expression Induced by Simvastatin in 3T3-L1 Adipocytes 2013 ·Metabolic Syndrome and Related Disorders ·(unknown), Matthew K. Ito	32
8	Predictors of statin adherence, switching, and discontinuation in the USAGE survey: Understanding the use of statins in America and gaps in patient education 2013 ·Journal of clinical lipidology ·Melissa Y. Wei, Matthew K. Ito, Jerome D. Cohen, Eliot A. Brinton, Terry A. Jacobson	195
9	The effect of acute café latte ingestion on fasting serum lipid levels in healthy individuals 2012 ·Journal of clinical lipidology ·(unknown), (unknown), Sung Hee Hong, (unknown), (unknown), Matthew K. Ito	12
10	Dyslipidemia: Management Using Optimal Lipid-Lowering Therapy 2012 ·Annals of Pharmacotherapy ·Matthew K. Ito	30
11	A systematic review on evidence of the effectiveness and safety of a wax-matrix niacin formulation 2011 ·Journal of clinical lipidology ·(unknown), Matthew K. Ito, Carlos A. Dujovne	3
12	Familial Hypercholesterolemia: Screening, diagnosis and management of pediatric and adult patients breakdown → 2011 ·Journal of clinical lipidology ·Anne C. Goldberg, Paul N. Hopkins, Peter P. Tóth, Christie M. Ballantyne, Daniel J. Rader, Jennifer G. Robinson, Stephen R. Daniels, Samuel S. Gidding, Sarah D. de Ferranti, Matthew K. Ito, Mary P. McGowan, Patrick M. Moriarty, William C. Cromwell, Joyce L. Ross, Paul Ziajka	465
13	Management of Familial Hypercholesterolemias in adult patients: Recommendations from the National Lipid Association Expert Panel on Familial Hypercholesterolemia 2011 ·Journal of clinical lipidology ·Matthew K. Ito, Mary P. McGowan, Patrick M. Moriarty	99
14	Long Chain Omega-3 Dietary Supplements: A Review of the National Library of Medicine Herbal Supplement Database 2011 ·Metabolic Syndrome and Related Disorders ·(unknown), Matthew K. Ito	33
15	Statin‐Associated Pleiotropy: Possible Beneficial Effects Beyond Cholesterol Reduction 2006 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Matthew K. Ito, Robert L. Talbert, Sotirios Tsimikas	43
16	Key Articles, Guidelines, and Consensus Papers Relative to the Treatment of Dyslipidemias—2005 2006 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·Matthew K. Ito, (unknown), (unknown), Kim K. Birtcher, Pang H Chong, Theresa Bianco, Barry E. Bleske	8
17	Ezetimibe: The First in a Novel Class of Selective Cholesterol-Absorption Inhibitors 2002 ·PubMed ·(unknown), Matthew K. Ito	30
18	Lovastatin and Extended-Release Niacin Combination Product: The First Drug Combination for the Management of Hyperlipidemia 2002 ·PubMed ·(unknown), Matthew K. Ito	42
19	Fenofibrate and Warfarin Interaction 2001 ·Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy ·(unknown), Matthew K. Ito	14
20	The monounsaturated fatty acid from avocado in the control of dyslipidaemia. 2000 ·Revista de Ciências Médicas ·(unknown), Matthew K. Ito	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact